z-logo
open-access-imgOpen Access
The Impact of a Pulmonary-Artery-Catheter-Based Protocol on Fluid and Catecholamine Administration in Early Sepsis
Author(s) -
Carina Bethlehem,
Frouwke M. Groenwold,
Hanneke Buter,
W. Peter Kingma,
Michaël Kuiper,
Fellery de Lange,
Paul Elbers,
Henk Groen,
Eric N. van Roon,
E. Christiaan Boerma
Publication year - 2012
Publication title -
critical care research and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.532
H-Index - 27
eISSN - 2090-1313
pISSN - 2090-1305
DOI - 10.1155/2012/161879
Subject(s) - medicine , pulmonary artery catheter , sepsis , catecholamine , anesthesia , norepinephrine , catheter , fluid intake , balance (ability) , randomized controlled trial , pulmonary artery , surgery , hemodynamics , cardiac output , physical therapy , dopamine
Objective . The pulmonary artery catheter (PAC) remains topic of debate. Despite abundant data, it is of note that many trials did not incorporate a treatment protocol. Methods . We retrospectively evaluated fluid balances and catecholamine doses in septic patients after the introduction of a PAC-based treatment protocol in comparison to historic controls. Results . 2 × 70 patients were included. The first day the PAC group had a significantly higher positive fluid balance in comparison to controls (6.1 ± 2.6 versus 3.8 ± 2.4 litre, P < 0.001). After 7 days the cumulative fluid balance in the PAC group was significantly lower than in controls (9.4 ± 7.4 versus 13 ± 7.6 litre, P = 0.001). Maximum dose of norepinephrine was significantly higher in the PAC group. Compared to controls this was associated with a significant reduction in ventilator and ICU days. Conclusions . Introduction of a PAC-based treatment protocol in sepsis changed the administration of fluid and vasopressors significantly.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom